{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:03:56Z","timestamp":1780373036736,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T00:00:00Z","timestamp":1095984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1038\/sj.eye.6701653","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T09:41:26Z","timestamp":1096018886000},"page":"846-853","source":"Crossref","is-referenced-by-count":63,"title":["High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits"],"prefix":"10.1038","volume":"19","author":[{"given":"L W","family":"Yip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B Y","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A W","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-W","family":"Khin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-H","family":"Chng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-J","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,24]]},"reference":[{"key":"BF6701653_CR1","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J et al. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987; 123: 1160\u20131165.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archderm.1991.01680050083008","volume":"127","author":"E Schopf","year":"1991","unstructured":"Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF . Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839\u2013842.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR3","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/S0161-6420(95)30811-1","volume":"102","author":"WJ Power","year":"1995","unstructured":"Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS . Analysis of the acute ophthalmic manifestations of the erythema multiforme\/Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis disease spectrum. Ophthalmology 1995; 102: 1669\u20131676.","journal-title":"Ophthalmology"},{"key":"BF6701653_CR4","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1034\/j.1398-9995.2002.02161.x","volume":"57","author":"W Pichler","year":"2002","unstructured":"Pichler W, Yawalkar N, Schmid S, Helbling A . Pathogenesis of drug-induced exanthems. Allergy 2002; 57: 884\u2013893.","journal-title":"Allergy"},{"key":"BF6701653_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490\u2013493.","journal-title":"Science"},{"key":"BF6701653_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000051702","volume":"203","author":"M Stella","year":"2001","unstructured":"Stella M, Cassano P, Bollero D, Clemente A, Giorio G . Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience. Dermatology 2001; 203: 45\u201349.","journal-title":"Dermatology"},{"key":"BF6701653_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/archderm.139.1.26","volume":"139","author":"C Prins","year":"2003","unstructured":"Prins C, Kerdel FA, Padilla RS, Hunziker T, Chimenti S, Viard I et al. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003; 139: 26\u201332.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1067\/mjd.2002.127249","volume":"47","author":"P Tristani-Firouzi","year":"2002","unstructured":"Tristani-Firouzi P, Petersen MJ, Saffle JR, Morris SE, Zone JJ . Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 2002; 47: 548\u2013552.","journal-title":"J Am Acad Dermatol"},{"key":"BF6701653_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC . Intravenous immunoglobulin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 2003; 139: 33\u201336.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/archopht.1973.01000050378008","volume":"90","author":"MJ Arstikaitis","year":"1973","unstructured":"Arstikaitis MJ . Ocular aftermath of Stevens\u2013Johnson syndrome. Arch Ophthalmol 1973; 90: 376\u2013379.","journal-title":"Arch Ophthalmol"},{"key":"BF6701653_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC . Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92\u201396.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2133.1967.tb11434.x","volume":"79","author":"A Lyell","year":"1967","unstructured":"Lyell A . A review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967; 79: 662\u2013671.","journal-title":"Br J Dermatol"},{"key":"BF6701653_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archderm.1984.01650420031010","volume":"120","author":"ED Westly","year":"1984","unstructured":"Westly ED, Wechsler HL . Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch Dermatol 1984; 120: 721\u2013726.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0190-9622(85)70207-1","volume":"13","author":"R Ruiz-Maldonado","year":"1985","unstructured":"Ruiz-Maldonado R . Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases. J Am Acad Dermatol 1985; 13: 623\u2013635.","journal-title":"J Am Acad Dermatol"},{"key":"BF6701653_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/00000658-198611000-00001","volume":"204","author":"PH Halebian","year":"1986","unstructured":"Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT . Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg 1986; 204: 503\u2013512.","journal-title":"Ann Surg"},{"key":"BF6701653_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0022-3476(89)80736-X","volume":"115","author":"JS Prendiville","year":"1989","unstructured":"Prendiville JS, Hebert AA, Greenwald MJ, Esterly NB . Management of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989; 115: 881\u2013887.","journal-title":"J Pediatr"},{"key":"BF6701653_CR17","first-page":"273","volume":"180","author":"JJ Kelemen III","year":"1995","unstructured":"Kelemen III JJ, Cioffi WG, McManus WF, Mason Jr AD, Pruitt Jr BA . Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg 1995; 180: 273\u2013278.","journal-title":"J Am Coll Surg"},{"key":"BF6701653_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1440-0960.1999.00342.x","volume":"40","author":"KC Wong","year":"1999","unstructured":"Wong KC, Kennedy PJ, Lee S . Clinical manifestations and outcomes in 17 cases of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol 1999; 40: 131\u2013134.","journal-title":"Australas J Dermatol"},{"key":"BF6701653_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(85)92146-4","volume":"1","author":"JC Roujeau","year":"1985","unstructured":"Roujeau JC, Phlippoteau C, Koso M, Wechsler J, Andre C, Binaghi M et al. Sjogren-like syndrome after drug-induced toxic epidermal necrolysis. Lancet 1985; 1: 609\u2013611.","journal-title":"Lancet"},{"key":"BF6701653_CR20","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/archderm.1987.01660330067010","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R . Treatment of toxic epidermal necrolysis. Creteil's experience. Arch Dermatol 1987; 123: 1156\u20131158.","journal-title":"Arch Dermatol"},{"key":"BF6701653_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00130832-200308000-00006","volume":"3","author":"N Bachot","year":"2003","unstructured":"Bachot N, Roujeau JC . Intravenous immunoglobulins in the treatment of severe drug eruptions. Curr Opin Allg Clin Immunol 2003; 3: 269\u2013274.","journal-title":"Curr Opin Allg Clin Immunol"},{"key":"BF6701653_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","volume":"48","author":"JM Arevalo","year":"2000","unstructured":"Arevalo JM, Lorente JA, Gonzalez-Herrada C, Jimenez-Reyes J . Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma 2000; 48: 473\u2013478.","journal-title":"J Trauma"},{"key":"BF6701653_CR23","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1046\/j.1365-2133.1998.2576n.x","volume":"139","author":"A Trautmann","year":"1998","unstructured":"Trautmann A, Klein CE, Kampgen E, Brocker EB . Severe bullous drug reactions treated successfully with cyclophosphamide. Br J Dermatol 1998; 139: 1127\u20131128.","journal-title":"Br J Dermatol"},{"key":"BF6701653_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","volume":"6","author":"G Bamichas","year":"2002","unstructured":"Bamichas G, Natse T, Christidou F, Stangou M, Karagianni A, Koukourikos S et al. Plasma exchange in patients with toxic epidermal necrolysis. Ther Apher 2002; 6: 225\u2013228.","journal-title":"Ther Apher"},{"key":"BF6701653_CR25","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998; 352: 1586\u20131589.","journal-title":"Lancet"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701653","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:18:38Z","timestamp":1684412318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,24]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["BF6701653"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701653","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,24]]}}}